ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2171

A Comparison of Maternal Outcomes in Women with and without Juvenile Idiopathic Arthritis

Debbie Ehrmann Feldman1, Sasha Bernatsky2, Evelyne Vinet3, Ciarán M. Duffy4, Elizabeth Hazel5, Garbis Meshefedjian6, Marie-Pierre Sylvestre7 and Anick Bérard1, 1Université de Montréal, Montréal, QC, Canada, 2Rheum/Clin. Epid., McGill MUHC/RVH, Montreal, QC, Canada, 3McGill University Health Centre, Montreal, QC, Canada, 4Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 5Rhematology, McGill University Health Centre, Montreal, QC, Canada, 6Public Health Department of Montreal, Montreal, QC, Canada, 7Université de Montréal, Montreal, QC, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: juvenile idiopathic arthritis (JIA), outcomes and pregnancy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: ARHP III: Epidemiology and Public Health

Session Type: ARHP Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Although there is a higher frequency of adverse maternal outcomes in mother with rheumatoid arthritis, little is known regarding mothers with juvenile idiopathic arthritis (JIA). Our objective was to determine whether women with a history of JIA have more adverse maternal outcomes than mothers who never had JIA.  

Methods:

Our cohort study used data from physician billing and hospitalizations covering Québec, Canada. We identified all females with JIA with a first-time birth between 01/01/1983 and 12/31/2010, and assembled a control cohort of first-time mothers without JIA from the same administrative data, matching 4:1 for date of first birth, maternal age and area of residence. We compared maternal outcomes (hypertension, diabetes, preeclampsia/eclampsia) in the JIA versus non-JIA groups, using logistic regression. We adjusted for maternal education, and socioeconomic status (as measured by a geographic deprivation index).

Results:

Mean age at delivery was 24.7 years in the JIA group (n=1681) and 25.0 for the non-JIA group (n=6724). Mothers with JIA were more likely to have hypertension during pregnancy compared with those who did not have JIA (8.5% (95% confidence interval (CI) 7.3,9.9) vs 4.6%, 95% CI 4.2,5.2 ). The proportion in the JIA group with preeclampsia/eclampsia  was 3.8% (95% CI 2.9,4.8)vs 2.8% (95% CI  2.4,3.2 ) in the non JIA group and the proportion with diabetes during pregnancy was 0.9% (95% CI 0.5,1.5 ) in the JIA group vs 0.6% in the non JIA group (95% CI 0.4,0.8). Among JIA mothers, 99% who had hypertension during pregnancy also had pre-pregnancy hypertension compared with 57% in the non JIA group. Similarly, 100% who had diabetes during pregnancy had pre-pregnancy diabetes in the JIA group vs. 63% in the non JIA group.  In multivariate analyses, women with JIA were more likely to have hypertension during pregnancy (odds ratio (OR) 1.89, 95% confidence interval (CI) 1.55,2.28), but not preeclampsia/eclampsia (OR 1.06, 95% CI 0.80,1.42) compared to control women; the OR for diabetes during pregnancy (1.66, 95% CI 0.91,3.02) was inconclusive.   Lower socioeconomic status was associated with all three adverse maternal outcomes in the entire group. 

Conclusion:

Mothers with JIA were more likely to have hypertension during pregnancy compared to women without JIA. Further studies would be useful to assess the impact of medications and other factors (e.g. obesity) on maternal outcomes in JIA.


Disclosure: D. Ehrmann Feldman, None; S. Bernatsky, None; E. Vinet, None; C. M. Duffy, None; E. Hazel, None; G. Meshefedjian, None; M. P. Sylvestre, None; A. Bérard, None.

To cite this abstract in AMA style:

Ehrmann Feldman D, Bernatsky S, Vinet E, Duffy CM, Hazel E, Meshefedjian G, Sylvestre MP, Bérard A. A Comparison of Maternal Outcomes in Women with and without Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/a-comparison-of-maternal-outcomes-in-women-with-and-without-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-comparison-of-maternal-outcomes-in-women-with-and-without-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology